SEC Form 4 · accession 0001645627-18-000005
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 22, 2018
Accepted (ET)
Jan 29, 2018 · 5:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2018 | P | 1,000 | $0.0579 | A | 24,741,189 | D | |
| Common Stock | Jan 22, 2018 | P | 2,000 | $0.0588 | A | 24,743,189 | D | |
| Common Stock | Jan 23, 2018 | P | 2,000 | $0.056 | A | 24,745,189 | D | |
| Common Stock | Jan 24, 2018 | P | 3,000 | $0.0567 | A | 24,748,189 | D | |
| Common Stock | Jan 24, 2018 | P | 2,000 | $0.0567 | A | 24,750,159 | D | |
| Common Stock | Jan 25, 2018 | P | 1,000 | $0.055 | A | 24,751,189 | D | |
| Common Stock | Jan 25, 2018 | P | 2,000 | $0.055 | A | 24,753,189 | D | |
| Common Stock | Jan 25, 2018 | P | 2,000 | $0.0558 | A | 24,755,189 | D | |
| Common Stock | Jan 25, 2018 | P | 2,000 | $0.0558 | A | 24,757,189 | D | |
| Common Stock | Jan 26, 2018 | P | 2,000 | $0.0558 | A | 24,759,189 | D | |
| Common Stock | Jan 26, 2018 | P | 2,000 | $0.0539 | A | 24,761,189 | D |
Table II — derivative securities
No Table II lines on this filing.